Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 442 participants.

Also called NCT01870401

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 442 participants (enrolled count) (from the registry)
Sponsor
  • C. R. Bard Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01870401
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Belgium, Canada, Germany, Italy, Japan, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01870401. Randomized; single masking; primary purpose treatment. Start 2013-06-03 (actual); primary completion 2018-05-17 (actual). Results posted on 2020-08-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries
Condition
Critical Limb Ischemia
Intervention (Device)
Lutonix DCB
Intervention (Device)
Uncoated PTA Catheter
Lead sponsor
C. R. Bard (class: industry)
Collaborator
Bard Ltd (class: industry)

Record details

Record id
cardio:ct-nct01870401
Content hash
000ed802e55ea8abb4c6cdebcd21da8cae703b010b7e63561a9f199360f2b7c0